AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.

Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to ...

AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Studies suggest collagen supplementation may help improve conditions such as osteoarthritis, osteoporosis, sarcopenia, ...

Bloating is a common digestive issue affecting people of all ages, however, the experience becomes more frequent and severe ...

Widely used by the food industry, emulsifiers – a type of food additive – are found in many daily foods (sliced bread, ice ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

The late research pioneer Roberta (“Bobbie”) Colman, Willis F. Harrington Professor of Chemistry and Biochemistry at UD, had ...